VXA-CoV2-1

VXA-CoV2-1 Uses, Dosage, Side Effects, Food Interaction and all others data.

VXA-CoV2-1 is a non-replicating adenoviral vector-based oral tableted vaccine candidate that expresses a SARS-CoV-2 antigen and dsRNA adjuvant. This oral vaccine aims to induce immunogenicity through induction of potent serum neutralizing antibodies to the SARS-CoV-2 spike protein, induction of mucosal immune responses, and induction of T-cell responses to both vaccine antigens of the SARS-CoV-2 nucleocapsid and spike proteins.

Trade Name VXA-CoV2-1
Generic VXA-CoV2-1
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
VXA-CoV2-1
VXA-CoV2-1

Innovators Monograph

You find simplified version here VXA-CoV2-1


*** Taking medicines without doctor's advice can cause long-term problems.
Share